Document is current
Any future updates will be listed below
-
Authors
De Lott, Lindsey B.
Bennett, Jeffrey L.
Costello, Fiona
-
Funding
Funding for this research was provided by:
National Eye Institute (K23EY027849)
- License Information
-
More Information
Article History
Received: 10 September 2020
Revised: 2 December 2020
Accepted: 4 December 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Dr. De Lott is supported by the National Institutes of Health, Bethesda, MD (K23EY027849). Dr. Bennett is supported by the National Institutes of Health (R01EY022936, R01NS115488) and the Guthy Jackson Charitable Foundation. Dr. Bennett reports payment for study design/consultation from MedImmune/Viela Bio, personal fees from AbbVie, Alexion, Chugai, Clene Nanomedicine, Equillium, Frequency Therapeutics, Genentech, Mitsubishi-Tanabe, Reistone-Bio, and Roche, grants and personal fees from Novartis, grants from Mallinckrodt, and has a patent for Aquaporumab issued. Dr. Costello has received payments for consultation from Roche, Alexion, and Frequency Therapeutics.
: Not applicable.
: The manuscript does not contain clinical studies or patient data.
: Not applicable.
: Not applicable.
